Cardia adenocarcinoma auxiliary diagnosis kit related to a group of genes
A technique for assisting the diagnosis of cardiac adenocarcinoma, which is applied in the fields of biomedicine and molecular biology, and can solve difficult clinical problems, low specificity, and low sensitivity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0037] The preparation of embodiment 1 specimen
[0038] 1.1 Specimen source
[0039] From October 2014 to December 2017 in Anyang Cancer Hospital, 651 patients diagnosed with cardia adenocarcinoma were selected and included in the patient group. The inclusion criteria are as follows:
[0040] (1) Cases undergoing surgical resection;
[0041] (2) Cardia adenocarcinoma diagnosed by postoperative pathology with corresponding paracancerous tissue, which is defined as cardiac tissue beyond 5cm from the tumor edge;
[0042] (3) None of the patients received preoperative neoadjuvant therapy.
[0043] Select the same number of healthy volunteers as a group of healthy volunteers. "Healthy volunteers" were defined as volunteers who did not find any pathological changes in the upper gastrointestinal tract, including positive changes, after gastroscopy.
[0044] 1.2 Patient group tissue samples
[0045] In the patient group, after surgical resection of cardiac adenocarcinoma tissue...
Embodiment 2
[0050] Example 2 RT-PCR method to study the expression difference of genes BCL2L1, DLC1, CDKN2A, CDKN2B, NRG1, Erb B4 in cardia adenocarcinoma and adjacent tissues
[0051] 2.1 Experimental method
[0052] 2.1.1 RNA extraction from tissue samples
[0053] The cardia adenocarcinoma tissues and corresponding paracancerous tissues derived from the patient group in Example 1 were respectively subjected to RNA extraction according to the numbers, and the cardiac adenocarcinoma tissues and corresponding paracancerous tissues of each case were grouped into one group, and the cardiac adenocarcinoma tissues were used as The experimental samples and the corresponding paracancerous tissues were used as control samples, and 651 patients were divided into 651 groups.
[0054] Reagent (invitrogen, Cat. No. 15596-018) was used to extract RNA from 651 groups of samples, and the experimental operation was carried out according to the product instructions. The specific operation of each group ...
Embodiment 3
[0076] Example 3 Study of the expression differences of genes BCL2L1, DLC1, CDKN2A, CDKN2B, NRG1, and Erb B4 in cardia adenocarcinoma and adjacent tissues by immunohistochemical staining
[0077] 3.1 Tissue staining
[0078] The cardiac adenocarcinoma tissue and paracancerous tissue samples of 651 patients in the patient group were processed as follows:
[0079] The specimens were fixed with 4% paraformaldehyde at room temperature for 24h to 72h, embedded in paraffin, and made into 5mm sections. Paraffin sections were dewaxed in xylene, dehydrated in graded ethanol, and placed in 0.3% H 2 o 2 -Incubate in methanol solution for 30 minutes at room temperature to eliminate endogenous peroxidase activity, wash with distilled water, and retrieve antigen by microwave method, soak in phosphate buffered saline (PBS) for 5 minutes, place in 1:10 goat serum blocking solution and incubate at room temperature for 10 minutes.
[0080] Each sample obtained after the above steps was rando...
PUM
Property | Measurement | Unit |
---|---|---|
molecular weight | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com